相关实验视频
Updated: Jun 13, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
新的生物药物:哪些患有喘的孩子应该得到什么?
K Hillson1,2, S Saglani1,2, A Bush1,2
1National Heart and Lung Institute, Imperial College London, London, UK.
Pediatric pulmonology
|September 13, 2024
概括
选择适合儿童严重喘的生物疗法至关重要. 虽然有几种单克隆抗体,但疗效不同,需要更多的对比试验来指导儿童的治疗决定.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的儿童喘管理已经被新的生物疗法所改变,主要是单克隆抗体.
- 准确选择适合个别儿科患者的生物制剂对于最佳结果至关重要.
- 在英国,四种生物药物被授权用于重症儿科喘:奥马利祖马布,梅波利祖马布,杜皮卢马布 (≥6年) 和特泽佩卢马布 (≥12年).
研究的目的:
- 审查当前用于严重儿童喘的生物药物的证据基础.
- 突出适当的生物选择的重要性以及现有的儿科数据的局限性.
- 强调需要进行持续的研究,包括对比试验和对成年人数据的仔细推断.
主要方法:
- 在英国对治疗严重儿科喘的许可生物药物的审查.
- 对目前关于疗效,安全性和患者反应能力的证据的分析.
- 考虑正在进行的临床试验,例如TREAT研究,比较奥马利祖马布和梅波利祖马布.
主要成果:
- 在获得许可的生物药物中,Tezepelumab在没有2型炎症的严重喘中具有独特的潜在疗效.
- 所有批准的生物制剂都显示出良好的安全性,但临床疗效在儿童中显著不同.
- 儿童严重喘群体中缺乏随机,对比性试验,比较不同的生物药物.
结论:
- 在选择生物制剂时,仔细考虑个体患者的因素和有限的儿科证据至关重要.
- 从成人数据推断到儿童的数据必须谨慎地进行,因为病理生理学和生物标志物的潜在差异.
- 需要定期对患者进行检查,以评估生物治疗的疗效和安全性,并确定治疗的适当持续时间.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
01:19Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
01:17Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228